Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis

The Journal of Rheumatology
Takashi TaniguchiShinichi Sato

Abstract

CXCL6, a chemokine with proangiogenic property, is reported to be involved in vasculopathy associated with systemic sclerosis (SSc). We investigated the contribution of CXCL6 to SSc development by focusing on the association of friend leukemia virus integration 1 (Fli1) deficiency, a potential predisposing factor of SSc, with CXCL6 expression and clinical correlation of serum CXCL6 levels. mRNA levels of target genes and the binding of Fli1 to the CXCL6 promoter were evaluated by quantitative reverse transcription-PCR and chromatin immunoprecipitation, respectively. Serum CXCL6 levels were determined by ELISA. FLI1 siRNA significantly enhanced CXCL6 mRNA expression in human dermal fibroblasts and human dermal microvascular endothelial cells, while Fli1 haploinsufficiency significantly suppressed CXCL6 mRNA expression in murine peritoneal macrophages stimulated with lipopolysaccharide. Supporting a critical role of Fli1 deficiency to induce SSc-like phenotypes, CXCL6 mRNA expression was higher in SSc dermal fibroblasts than in normal dermal fibroblasts. Importantly, Fli1 bound to the CXCL6 promoter in dermal fibroblasts, endothelial cells, and THP-1 cells. In patients with SSc, serum CXCL6 levels correlated positively with the s...Continue Reading

References

Jul 24, 2003·The American Journal of Pathology·Masahide KuboMaria Trojanowska
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrick LaplanteMarie-Josée Hébert
Dec 14, 2005·Gastroenterology·Tarik AsselahPatrick Marcellin
Aug 9, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Johannes PammerErwin Tschachler
Mar 12, 2010·Journal of Cellular and Molecular Medicine·Nicole ReichJörg H W Distler
Mar 17, 2010·The American Journal of Pathology·Yoshihide AsanoMaria Trojanowska
Aug 27, 2013·Journal of Leukocyte Biology·Anne-Gaëlle BesnardBernhard Ryffel
Oct 30, 2013·The Prostate·George S KaragiannisEleftherios P Diamandis
Dec 3, 2013·Archives of Dermatological Research·Yohei IchimuraTakafumi Kadono
Aug 20, 2014·Nature Reviews. Rheumatology·Jasper C A BroenMarzia Rossato
Aug 30, 2014·World Journal of Gastroenterology : WJG·Giada SebastianiKostas Pantopoulos
Oct 18, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Hui TianJinglin Xia
Dec 17, 2014·Nature Communications·Shinji NodaShinichi Sato
Jun 10, 2015·The International Journal of Biochemistry & Cell Biology·Yoshihide Asano
Jul 15, 2015·Seminars in Immunopathology·Yoshihide Asano, Shinichi Sato
Aug 14, 2015·Annals of the Rheumatic Diseases·Mirko ManettiMarco Matucci-Cerinic
Feb 25, 2017·The Journal of Experimental Medicine·Takehiro TakahashiShinichi Sato

❮ Previous
Next ❯

Citations

Jan 4, 2019·Biomarkers in Medicine·Xiufang WangAiping Deng
Dec 12, 2017·The Journal of Dermatology·Yoshihide Asano
Dec 7, 2018·The Journal of Investigative Dermatology·Takashi YamashitaShinichi Sato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.